/PRNewswire/ Nasus Pharma a privately held clinical-stage biopharmaceutical company developing a powder-based intranasal (PBI) product portfolio to address.
/PRNewswire/ Nasus Pharma a privately held clinical-stage biopharmaceutical company developing a powder-based intranasal (PBI) product portfolio to address.
NP-003 study terminated early with high significance in reducing viral infection. TEL AVIV , Israel, Nov. 24, 2021 /PRNewswire/ Nasus Pharma a privately held clinical-stage biopharmaceutical
Yemen: Weekly Epidemiological Bulletin: Volume 09, lssue 14, Epi week 14,(5-11 April ,2021) [EN/AR]
Format
During week no.14,2021, %93 health facilites provided valid surveillance data.
The total number of consultation reported during the week was 298235 compared to 292659 the previous reporting week 14 Acute respiratory tract infections lower Respiratory Infections (LRTI), Upper Respiratory Infections (URTI), Other acute diarrhea (OAD) and Malaria (Mal) were the leading cause of morbidity this week.
A total of 1462 alerts were generated by eDEWS system in week 14- 2021, Of these 1460 alerts were verified as true for further investigations with appropriate response
Leading causes of morbidity mortality in Epi-Week 14,2021
(URTI) 13.6%, suspected Malaria (7.3%),(DD) (7.1%) and (LRTI) (6.1%)Remain the leading causes of morbidity representing a total of (34.1%)
COVID-19: Durch Corona-Maßnahmen erhöhtes Risiko für andere Infektionskrankheiten? heilpraxisnet.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from heilpraxisnet.de Daily Mail and Mail on Sunday newspapers.